OCULUS INC. financial data

Symbol
OVTZ on OTC
Location
Vancouver
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 63.5 % -60.1%
Return On Assets -1.04K % -182%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91.4M shares 0%
Common Stock, Shares, Outstanding 91.4M shares 0%
Entity Public Float 4M USD 0%
Common Stock, Value, Issued 46.9M USD 0%
Weighted Average Number of Shares Outstanding, Basic 91.4M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Research and Development Expense 1.48K USD -82.7%
General and Administrative Expense 111K USD +72.8%
Costs and Expenses 343K USD +3.41%
Net Income (Loss) Attributable to Parent -343K USD -4.84%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.2K USD +337%
Assets 25.2K USD +51.9%
Accounts Payable, Current 265K USD +212%
Liabilities, Current 692K USD +108%
Accumulated Other Comprehensive Income (Loss), Net of Tax -31.2K USD +5.13%
Retained Earnings (Accumulated Deficit) -49M USD -0.71%
Stockholders' Equity Attributable to Parent -667K USD -111%
Liabilities and Equity 25.2K USD +51.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.29K USD +94.6%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 91.4M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.62K USD +94.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 7.11M USD -0.51%
Deferred Tax Assets, Gross 7.11M USD -0.51%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -350K USD -7.98%
Deferred Tax Assets, Operating Loss Carryforwards 6.93M USD -0.03%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 250M shares 0%
Additional Paid in Capital 1.49M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares